T Cell Receptor Depletion in Stem Cell Transplant

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
48 patients (estimated)
Sponsors
University of Minnesota - Masonic Cancer Center
Tags
T Cell (Allogeneic), Chemotherapy, Monoclonal Antibody, Adoptive Cellular Therapy, CD20, Steroid, Radiation Therapy
Trial Type
Treatment
Last Update
SparkCures ID
1579
NCT Identifier
NCT03579875

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.